• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非重症肌无力患者中,放射免疫分析与固定细胞基础分析的一致性:优化诊断方法。

Concordance between radioimmunoassay and fixed cell-based assay in subjects without myasthenia gravis: optimizing the diagnostic approach.

机构信息

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.

Department of Chemistry and Clinical Biochemistry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

出版信息

Eur J Neurol. 2024 Dec;31(12):e16435. doi: 10.1111/ene.16435. Epub 2024 Aug 8.

DOI:10.1111/ene.16435
PMID:39118440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11554847/
Abstract

BACKGROUND AND PURPOSE

Acetylcholine receptor antibody (AChR-Ab) detection is crucial in myasthenia gravis (MG) diagnosis and, currently, the radioimmunoassay (RIA) is the gold standard. However, RIA may detect AChR-Ab against nonpathogenic intracellular epitopes. In this study, we performed fixed cell-based assay (F-CBA) in RIA-AChR-Ab positive subjects without MG symptoms, to assess whether F-CBA could show a higher specificity compared to RIA in detecting pathogenic Abs.

METHODS

We reviewed medical records of patients referred to our MG outpatient clinic because of RIA-AChR-Ab detection. MG diagnosis was based on clinical examination, electrophysiology and Ab detection. AChR-Abs were tested by RIA in the whole cohort. Serum samples from RIA-positive asymptomatic subjects were retested by F-CBA.

RESULTS

Of 605 subjects who tested RIA-AChR-Ab positive, MG diagnosis was confirmed in 599. Six subjects were RIA-AChR-Ab positive although they had never had MG symptoms; in four of these subjects AChR-Abs were not detected by F-CBA, whereas the remaining two (both non-MG thymoma cases) were positive also by F-CBA.

CONCLUSIONS

RIA false positivity for AChR-Ab is very rare. Previous literature has demonstrated that F-CBA has higher sensitivity than RIA for MG, especially in ocular cases. Our preliminary results show that, in rare instances, F-CBA may be more specific than RIA for MG diagnosis.

摘要

背景与目的

乙酰胆碱受体抗体(AChR-Ab)的检测对重症肌无力(MG)的诊断至关重要,目前放射免疫分析(RIA)是金标准。然而,RIA 可能会检测到针对非致病性细胞内表位的 AChR-Ab。在这项研究中,我们对无 MG 症状但 RIA-AChR-Ab 阳性的受试者进行了基于固定细胞的检测(F-CBA),以评估 F-CBA 在检测致病性 Abs 方面是否比 RIA 具有更高的特异性。

方法

我们回顾了因 RIA-AChR-Ab 检测而转诊至我们 MG 门诊的患者的病历。MG 诊断基于临床检查、电生理学和 Ab 检测。在整个队列中通过 RIA 检测 AChR-Abs。对 RIA 阳性无症状受试者的血清样本进行 F-CBA 复测。

结果

在 605 例 RIA-AChR-Ab 阳性的受试者中,599 例确诊为 MG。有 6 例受试者尽管从未有过 MG 症状,但 RIA-AChR-Ab 阳性;在这 4 例受试者中,F-CBA 未检测到 AChR-Abs,而其余 2 例(均为非 MG 胸腺瘤病例)也通过 F-CBA 呈阳性。

结论

RIA 对 AChR-Ab 的假阳性非常罕见。既往文献表明,F-CBA 对 MG 的敏感性高于 RIA,尤其是在眼肌型病例中。我们的初步结果表明,在极少数情况下,F-CBA 可能比 RIA 更具特异性,有助于 MG 的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/930d/11554847/03df7c579ae9/ENE-31-e16435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/930d/11554847/03df7c579ae9/ENE-31-e16435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/930d/11554847/03df7c579ae9/ENE-31-e16435-g001.jpg

相似文献

1
Concordance between radioimmunoassay and fixed cell-based assay in subjects without myasthenia gravis: optimizing the diagnostic approach.在非重症肌无力患者中,放射免疫分析与固定细胞基础分析的一致性:优化诊断方法。
Eur J Neurol. 2024 Dec;31(12):e16435. doi: 10.1111/ene.16435. Epub 2024 Aug 8.
2
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.固定细胞和活细胞检测在重症肌无力乙酰胆碱受体和肌肉特异性激酶抗体检测中的比较。
Neurol Neuroimmunol Neuroinflamm. 2022 Oct 21;10(1). doi: 10.1212/NXI.0000000000200038. Print 2023 Jan.
3
Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.中国天津重症肌无力患者的非放射性血清学诊断及临床特征。
J Neurol Sci. 2011 Feb 15;301(1-2):71-6. doi: 10.1016/j.jns.2010.10.023. Epub 2010 Dec 4.
4
Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis.比较固定细胞基础测定法与放射免疫沉淀法检测重症肌无力乙酰胆碱受体抗体。
J Neurol Sci. 2022 Jan 15;432:120084. doi: 10.1016/j.jns.2021.120084. Epub 2021 Dec 8.
5
Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.日本胸腺瘤组织学与肌特异性受体酪氨酸激酶抗体阳性重症肌无力伴发自身免疫性疾病的相关性。
Eur J Neurol. 2013 Sep;20(9):1272-6. doi: 10.1111/ene.12169. Epub 2013 May 17.
6
Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population.在南亚人群中使用放射免疫沉淀法和基于细胞的检测方法对重症肌无力进行临床和血清学研究。
J Neurol Sci. 2014 Aug 15;343(1-2):82-7. doi: 10.1016/j.jns.2014.05.037. Epub 2014 May 27.
7
Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.南非队列中乙酰胆碱受体抗体阴性重症肌无力的特征
Muscle Nerve. 2016 Dec;54(6):1023-1029. doi: 10.1002/mus.25154. Epub 2016 Oct 13.
8
A novel MuSK cell-based myasthenia gravis diagnostic assay.一种新型基于 MuSK 细胞的重症肌无力诊断检测方法。
J Neuroimmunol. 2019 Dec 15;337:577076. doi: 10.1016/j.jneuroim.2019.577076. Epub 2019 Oct 19.
9
Detection of Autoantibodies Against the Acetylcholine Receptor, Evaluation of Commercially Available Methodologies: Fixed Cell-Based Assay, Radioimmunoprecipitation Assay and Enzyme-Linked Immunosorbent Assay1.抗乙酰胆碱受体自身抗体的检测:市售方法的评估——基于固定细胞的检测法、放射免疫沉淀法和酶联免疫吸附测定法1
J Neuromuscul Dis. 2024;11(3):613-623. doi: 10.3233/JND-230210.
10
A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis.一种使用BC3H-1细胞检测乙酰胆碱受体抗体的敏感玫瑰花结试验:“抗体阴性”重症肌无力患者的阳性结果
J Neuroimmunol. 1990 Jun;28(1):83-93. doi: 10.1016/0165-5728(90)90043-m.

引用本文的文献

1
Case Series of Canine Myasthenia Gravis: A Classification Approach With Consideration of Seronegative Dogs.犬重症肌无力病例系列:一种考虑血清阴性犬的分类方法。
J Vet Intern Med. 2025 May-Jun;39(3):e70113. doi: 10.1111/jvim.70113.
2
Testing for Acetylcholine Receptor and Muscle-Specific Tyrosine Kinase Antibodies by Fixed Cell-Based Assay in Clinical Practice: Positive Predictive Value for Myasthenia Gravis.临床实践中采用固定细胞法检测乙酰胆碱受体抗体和肌肉特异性酪氨酸激酶抗体:重症肌无力的阳性预测值
Eur J Neurol. 2025 Mar;32(3):e70123. doi: 10.1111/ene.70123.

本文引用的文献

1
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies.重症肌无力:分子治疗时代不断变化的治疗前景。
Nat Rev Neurol. 2024 Feb;20(2):84-98. doi: 10.1038/s41582-023-00916-w. Epub 2024 Jan 8.
2
A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study.一项比较自身抗体诊断检测在重症肌无力中准确性的多中心、前瞻性、双盲研究:SCREAM研究
Lancet Reg Health West Pac. 2023 Jul 19;38:100846. doi: 10.1016/j.lanwpc.2023.100846. eCollection 2023 Sep.
3
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.
固定细胞和活细胞检测在重症肌无力乙酰胆碱受体和肌肉特异性激酶抗体检测中的比较。
Neurol Neuroimmunol Neuroinflamm. 2022 Oct 21;10(1). doi: 10.1212/NXI.0000000000200038. Print 2023 Jan.
4
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.基于细胞的检测方法在血清阴性重症肌无力特征分析中的临床价值。
J Neurol Neurosurg Psychiatry. 2022 Sep;93(9):995-1000. doi: 10.1136/jnnp-2022-329284. Epub 2022 Jul 14.
5
The clinical need for clustered AChR cell-based assay testing of seronegative MG.神经肌肉接头疾病血清阴性重症肌无力基于聚集乙酰胆碱受体细胞的检测的临床需求。
J Neuroimmunol. 2022 Jun 15;367:577850. doi: 10.1016/j.jneuroim.2022.577850. Epub 2022 Mar 25.
6
Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis.比较固定细胞基础测定法与放射免疫沉淀法检测重症肌无力乙酰胆碱受体抗体。
J Neurol Sci. 2022 Jan 15;432:120084. doi: 10.1016/j.jns.2021.120084. Epub 2021 Dec 8.
7
Subclinical myasthenia gravis in thymomas.胸腺瘤中的亚临床型重症肌无力
Lung Cancer. 2021 Feb;152:143-148. doi: 10.1016/j.lungcan.2020.12.010. Epub 2020 Dec 17.
8
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?眼肌型重症肌无力乙酰胆碱受体抗体阳性率:与年龄有关?
J Neurol. 2021 May;268(5):1803-1807. doi: 10.1007/s00415-020-10342-3. Epub 2021 Jan 2.
9
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.停止检测 VGKC 复合物自身抗体:仅要求检测 LGI1 和 CASPR2。
Pract Neurol. 2020 Oct;20(5):377-384. doi: 10.1136/practneurol-2019-002494. Epub 2020 Jun 28.
10
Myasthenia gravis.重症肌无力。
Nat Rev Dis Primers. 2019 May 2;5(1):30. doi: 10.1038/s41572-019-0079-y.